ADORA2A and neoplasm: Hence, blocking A2AR with IST has been indicated as a potential strategy against GBM by inducing immune responses against the tumor, enhancing the response to standard chemotherapy, and providing new perspectives for treating patients who receive this unfavorable diagnosis.